242 related articles for article (PubMed ID: 30732540)
1. Ayahuasca and Public Health: Health Status, Psychosocial Well-Being, Lifestyle, and Coping Strategies in a Large Sample of Ritual Ayahuasca Users.
Ona G; Kohek M; Massaguer T; Gomariz A; Jiménez DF; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
J Psychoactive Drugs; 2019; 51(2):135-145. PubMed ID: 30732540
[TBL] [Abstract][Full Text] [Related]
2. Acute Psychological Adverse Reactions in First-Time Ritual Ayahuasca Users: A Prospective Case Series.
Gómez-Sousa M; Jiménez-Garrido DF; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):163-171. PubMed ID: 33606432
[TBL] [Abstract][Full Text] [Related]
3. Ayahuasca Users in Estonia: Ceremonial Practices, Subjective Long-Term Effects, Mental Health, and Quality of Life.
Kaasik H; Kreegipuu K
J Psychoactive Drugs; 2020; 52(3):255-263. PubMed ID: 32299306
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of creative expression and entoptic phenomena as after-effects of repeated ayahuasca ceremonies.
Frecska E; Móré CE; Vargha A; Luna LE
J Psychoactive Drugs; 2012; 44(3):191-9. PubMed ID: 23061318
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.
Uthaug MV; Mason NL; Toennes SW; Reckweg JT; de Sousa Fernandes Perna EB; Kuypers KPC; van Oorsouw K; Riba J; Ramaekers JG
Psychopharmacology (Berl); 2021 Jul; 238(7):1899-1910. PubMed ID: 33694031
[TBL] [Abstract][Full Text] [Related]
6. Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.
dos Santos RG
J Psychoactive Drugs; 2013; 45(1):68-78. PubMed ID: 23662333
[TBL] [Abstract][Full Text] [Related]
7. Changes in spirituality among ayahuasca ceremony novice participants.
Trichter S; Klimo J; Krippner S
J Psychoactive Drugs; 2009 Jun; 41(2):121-34. PubMed ID: 19705674
[TBL] [Abstract][Full Text] [Related]
8. Effects of ayahuasca on mental health and quality of life in naïve users: A longitudinal and cross-sectional study combination.
Jiménez-Garrido DF; Gómez-Sousa M; Ona G; Dos Santos RG; Hallak JEC; Alcázar-Córcoles MÁ; Bouso JC
Sci Rep; 2020 Mar; 10(1):4075. PubMed ID: 32139811
[TBL] [Abstract][Full Text] [Related]
9. Experiences of encounters with ayahuasca--"the vine of the soul".
Kjellgren A; Eriksson A; Norlander T
J Psychoactive Drugs; 2009 Dec; 41(4):309-15. PubMed ID: 20235436
[TBL] [Abstract][Full Text] [Related]
10. Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.
Bouso JC; Fábregas JM; Antonijoan RM; Rodríguez-Fornells A; Riba J
Psychopharmacology (Berl); 2013 Dec; 230(3):415-24. PubMed ID: 23793226
[TBL] [Abstract][Full Text] [Related]
11. Assessing the Psychedelic "After-Glow" in Ayahuasca Users: Post-Acute Neurometabolic and Functional Connectivity Changes Are Associated with Enhanced Mindfulness Capacities.
Sampedro F; de la Fuente Revenga M; Valle M; Roberto N; Domínguez-Clavé E; Elices M; Luna LE; Crippa JAS; Hallak JEC; de Araujo DB; Friedlander P; Barker SA; Álvarez E; Soler J; Pascual JC; Feilding A; Riba J
Int J Neuropsychopharmacol; 2017 Sep; 20(9):698-711. PubMed ID: 28525587
[TBL] [Abstract][Full Text] [Related]
12. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine.
Dos Santos RG; Valle M; Bouso JC; Nomdedéu JF; Rodríguez-Espinosa J; McIlhenny EH; Barker SA; Barbanoj MJ; Riba J
J Clin Psychopharmacol; 2011 Dec; 31(6):717-26. PubMed ID: 22005052
[TBL] [Abstract][Full Text] [Related]
13. Modulatory effects of ayahuasca on personality structure in a traditional framework.
Netzband N; Ruffell S; Linton S; Tsang WF; Wolff T
Psychopharmacology (Berl); 2020 Oct; 237(10):3161-3171. PubMed ID: 32700023
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of ayahuasca administered in two repeated doses.
Dos Santos RG; Grasa E; Valle M; Ballester MR; Bouso JC; Nomdedéu JF; Homs R; Barbanoj MJ; Riba J
Psychopharmacology (Berl); 2012 Feb; 219(4):1039-53. PubMed ID: 21842159
[TBL] [Abstract][Full Text] [Related]
15. Subacute effects of the psychedelic ayahuasca on the salience and default mode networks.
Pasquini L; Palhano-Fontes F; Araujo DB
J Psychopharmacol; 2020 Jun; 34(6):623-635. PubMed ID: 32255395
[TBL] [Abstract][Full Text] [Related]
16. Health status of ayahuasca users.
Barbosa PC; Mizumoto S; Bogenschutz MP; Strassman RJ
Drug Test Anal; 2012; 4(7-8):601-9. PubMed ID: 22761152
[TBL] [Abstract][Full Text] [Related]
17. The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study.
Maia LO; Daldegan-Bueno D; Tófoli LF
J Psychoactive Drugs; 2021; 53(3):272-282. PubMed ID: 33287690
[TBL] [Abstract][Full Text] [Related]
18. Effects of ayahuasca and its alkaloids on substance use disorders: an updated (2016-2020) systematic review of preclinical and human studies.
Rodrigues LS; Rossi GN; Rocha JM; L Osório F; Bouso JC; Hallak JEC; Dos Santos RG
Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):541-556. PubMed ID: 33914164
[TBL] [Abstract][Full Text] [Related]
19. A critical evaluation of reports associating ayahuasca with life-threatening adverse reactions.
dos Santos RG
J Psychoactive Drugs; 2013; 45(2):179-88. PubMed ID: 23909005
[TBL] [Abstract][Full Text] [Related]
20. Well-being, problematic alcohol consumption and acute subjective drug effects in past-year ayahuasca users: a large, international, self-selecting online survey.
Lawn W; Hallak JE; Crippa JA; Dos Santos R; Porffy L; Barratt MJ; Ferris JA; Winstock AR; Morgan CJA
Sci Rep; 2017 Nov; 7(1):15201. PubMed ID: 29123145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
